ArticleCancer reports (Hoboken, N.J.)2025

Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy.

Akihiro Ohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.